With Oct. 17 marking the sixth anniversary of Canada’s legalization of recreational cannabis, a Brock researcher says it’s time to examine how the process has impacted the medical cannabis market. Associate Professor of Operations Research Michael Armstrong’s new study shows that while the shift to nationwide legalization was accompanied by fewer patients in the medical market — access to recreational cannabis hasn’t made the program obsolete. “Overall, many patients did leave Canada’s medical cannabis system…
